Search

everythinglearnresearchcommunity

for

Search:↓

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Centella asiatica extract may help promote hair growth by blocking a specific cell signaling pathway.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

SLE and DM can coexist but are rare and need careful evaluation.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Blocking interferon-gamma might help treat various autoimmune diseases.